Abstract:Abstract Tumor-associated macrophages (TAMs) are the predominant immune cells within the tumor microenvironment (TME), and their phenotypic modulation is influenced by environmental cues in the TME. In early tumors, TAMs adopt a pro-inflammatory M1-like phenotype, characterized by the secretion of immunogenic cytokines and the ability to kill cancer cells, thus opposing tumorigenesis. However, as tumors progress, TAMs mainly transition to an anti-inflammatory M2-like phenotype, promoting angiogenesis, suppressing anti-tumor immunity, and supporting metastasis. Importantly, a high M2-like/M1-like TAM ratio correlates with poor survival and decreased treatment responses.Despite the significance of TAMs, the molecular mechanisms driving their pro-tumorigenic M2-like phenotype remain unclear. One potential mechanism is metabolic reprogramming, where, traditionally, M1 macrophages favor glycolysis, and M2 macrophages rely on oxidative phosphorylation. However, this paradigm is primarily derived from in vitro experiments using well-defined polarization cocktails, which may not accurately replicate the complex TME. For instance, while in in vitro experiments IL4 and IL13 can induce oxidative phosphorylation and an M2-like phenotype, these cytokines do not seem essential for M2-like TAM polarization in vivo.Our studies reveal that, relative to M1-like TAMs, M2-like TAMs exhibit heightened glycolysis, intracellular lactate accumulation, and increased histone lysine lactylation - an epigenetic mark directly stimulated by lactate. Importantly, we demonstrate that TAM glycolysis and the M2-like phenotype are positively associated with hypoxia within a single tumor (GEM model and human tumors) and across various tumor types (syngeneic models). Inhibition of glycolysis-stimulated lactate production in TAMs through myeloid cell-specific deletion of lactate dehydrogenase A (mLdha-/-) reduces the M2-like:M1-like TAM ratio. This intervention increases tumor-infiltrating CD8+ T cells and reduces tumor growth in pre-clinical models, particularly in highly hypoxic environments. Moreover, to exclude the role of cancer cell-derived lactate on TAMs’ phenotypic changes, we reduced glycolysis in cancer cells by deleting pyruvate kinase muscle isozyme M2 (PKM2). This resulted in decreased lactate production and suppressed tumor growth. However, the M2/M1 ratio remained unaffected, suggesting that the intrinsic lactate production by TAMs is crucial for their phenotype modulation.Our findings underscore the pivotal role of hypoxia-induced glycolysis and lactate production in TAMs, shaping their M2-like phenotype and impacting tumor progression. This understanding not only advances our knowledge of macrophage metabolism and phenotype dynamics in the context of cancer but also in other diseases. Citation Format: Katarzyna Kurylowicz, Kasturi Chakraborty, Chang Cui, Gustavo Gastão Davanzo, Guolin Zhou, Xu Anna Tang, Kelly Q. Schoenfelt, Natalie Pulliam, Catherine A. Reardon, Swati Kulkarni, Tomas Vaisar, Pedro M. Moraes-Vieira, Yingming Zhao, Lev Becker. Glycolysis-stimulated lactate production by tumor-associated macrophages promotes their M2-like phenotype [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 2686.

Lactate dehydrogenase B regulates macrophage metabolism in the tumor microenvironment

Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression

Unveiling the veil of lactate in tumor-associated macrophages: a successful strategy for immunometabolic therapy

Macrophage Transcriptome Modification Induced by Hypoxia and Lactate

Mir-182 Targeting Reprograms Tumor-Associated Macrophages and Limits Breast Cancer Progression

Targeting lactate dehydrogenase B-dependent mitochondrial metabolism affects tumor initiating cells and inhibits tumorigenesis of non-small cell lung cancer by inducing mtDNA damage

Lactate-induced lactylation circularly regulates glucose metabolism enzymes in breast cancer.

Decreased LDHB expression in breast tumor cells causes NK cell activation and promotes tumor progression

Lactate from glycolysis regulates inflammatory macrophage polarization in breast cancer

Targeting Lactate: An Emerging Strategy for Macrophage Regulation in Chronic Inflammation and Cancer

Lipid metabolism reprogramming in tumor-associated macrophages and implications for therapy

Mir-30A-5p Suppresses Breast Tumor Growth and Metastasis Through Inhibition of LDHA-mediated Warburg Effect

d -lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma

Targeting L-Lactate Metabolism to Overcome Resistance to Immune Therapy of Melanoma and Other Tumor Entities

Lactate metabolic pathway regulates tumor cell metastasis and its use as a new therapeutic target

Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK/STAT3 signaling pathway in breast cancer

Lactate Dehydrogenase-A (LDH-A) Preserves Cancer Stemness and Recruitment of Tumor-Associated Macrophages to Promote Breast Cancer Progression

Lactate induces tumor-associated macrophage polarization independent of mitochondrial pyruvate carrier-mediated metabolism

Macrophage-Specific Lactate Dehydrogenase Expression Modulates Inflammatory Function In Vitro

Abstract 2686: Glycolysis-stimulated lactate production by tumor-associated macrophages promotes their M2-like phenotype

Targeting macrophage metabolism to enhance tumor immunotherapy